nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP1A1—Dacarbazine—muscle cancer	0.165	0.185	CbGbCtD
Azelastine—CYP2E1—Dacarbazine—muscle cancer	0.128	0.143	CbGbCtD
Azelastine—CYP1A2—Dacarbazine—muscle cancer	0.0738	0.0827	CbGbCtD
Azelastine—CYP2E1—Etoposide—muscle cancer	0.0624	0.07	CbGbCtD
Azelastine—ABCB1—Dactinomycin—muscle cancer	0.0559	0.0627	CbGbCtD
Azelastine—CYP3A5—Vincristine—muscle cancer	0.0529	0.0593	CbGbCtD
Azelastine—CYP3A5—Etoposide—muscle cancer	0.0485	0.0544	CbGbCtD
Azelastine—CYP2C8—Etoposide—muscle cancer	0.0466	0.0523	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—muscle cancer	0.042	0.0471	CbGbCtD
Azelastine—CYP1A2—Etoposide—muscle cancer	0.0361	0.0405	CbGbCtD
Azelastine—ABCB1—Vincristine—muscle cancer	0.0344	0.0386	CbGbCtD
Azelastine—ABCB1—Etoposide—muscle cancer	0.0316	0.0354	CbGbCtD
Azelastine—ABCB1—Doxorubicin—muscle cancer	0.0215	0.0241	CbGbCtD
Azelastine—ABCB1—Methotrexate—muscle cancer	0.0208	0.0234	CbGbCtD
Azelastine—CYP3A4—Vincristine—muscle cancer	0.0206	0.0231	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—muscle cancer	0.0203	0.0227	CbGbCtD
Azelastine—CYP3A4—Etoposide—muscle cancer	0.0189	0.0212	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—muscle cancer	0.0129	0.0145	CbGbCtD
Azelastine—Ulcerative stomatitis—Dactinomycin—muscle cancer	0.00354	0.0328	CcSEcCtD
Azelastine—Mucosal inflammation—Etoposide—muscle cancer	0.00214	0.0198	CcSEcCtD
Azelastine—Ulcer—Dactinomycin—muscle cancer	0.00173	0.016	CcSEcCtD
Azelastine—Furunculosis—Methotrexate—muscle cancer	0.00167	0.0154	CcSEcCtD
Azelastine—Ulcerative stomatitis—Methotrexate—muscle cancer	0.00154	0.0142	CcSEcCtD
Azelastine—Mouth ulceration—Dactinomycin—muscle cancer	0.00148	0.0137	CcSEcCtD
Azelastine—Furuncle—Methotrexate—muscle cancer	0.00145	0.0134	CcSEcCtD
Azelastine—Furunculosis—Doxorubicin—muscle cancer	0.00144	0.0134	CcSEcCtD
Azelastine—Dysaesthesia—Doxorubicin—muscle cancer	0.00142	0.0131	CcSEcCtD
Azelastine—Ulcerative stomatitis—Doxorubicin—muscle cancer	0.00133	0.0123	CcSEcCtD
Azelastine—Mouth ulceration—Vincristine—muscle cancer	0.00132	0.0122	CcSEcCtD
Azelastine—Aphthous stomatitis—Doxorubicin—muscle cancer	0.00131	0.0121	CcSEcCtD
Azelastine—Mucosal inflammation—Methotrexate—muscle cancer	0.00128	0.0118	CcSEcCtD
Azelastine—Furuncle—Doxorubicin—muscle cancer	0.00125	0.0116	CcSEcCtD
Azelastine—Ulcer—Etoposide—muscle cancer	0.00125	0.0116	CcSEcCtD
Azelastine—Mucosal inflammation—Doxorubicin—muscle cancer	0.00111	0.0103	CcSEcCtD
Azelastine—Mouth ulceration—Etoposide—muscle cancer	0.00107	0.0099	CcSEcCtD
Azelastine—Urinary retention—Vincristine—muscle cancer	0.00101	0.00933	CcSEcCtD
Azelastine—Parosmia—Doxorubicin—muscle cancer	0.000946	0.00875	CcSEcCtD
Azelastine—Anaphylactoid reaction—Etoposide—muscle cancer	0.000887	0.00821	CcSEcCtD
Azelastine—Laryngitis—Doxorubicin—muscle cancer	0.000851	0.00788	CcSEcCtD
Azelastine—Albuminuria—Doxorubicin—muscle cancer	0.000822	0.0076	CcSEcCtD
Azelastine—Pharyngitis—Dactinomycin—muscle cancer	0.000815	0.00754	CcSEcCtD
Azelastine—Herpes simplex—Methotrexate—muscle cancer	0.000769	0.00711	CcSEcCtD
Azelastine—Glossitis—Methotrexate—muscle cancer	0.000769	0.00711	CcSEcCtD
Azelastine—Flushing—Dactinomycin—muscle cancer	0.000762	0.00705	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000758	0.00701	CcSEcCtD
Azelastine—Ageusia—Doxorubicin—muscle cancer	0.000757	0.00701	CcSEcCtD
Azelastine—Stinging—Doxorubicin—muscle cancer	0.000757	0.00701	CcSEcCtD
Azelastine—Ulcer—Methotrexate—muscle cancer	0.000749	0.00693	CcSEcCtD
Azelastine—Bronchospasm—Etoposide—muscle cancer	0.00073	0.00675	CcSEcCtD
Azelastine—Hypoaesthesia—Vincristine—muscle cancer	0.00073	0.00675	CcSEcCtD
Azelastine—Breast pain—Doxorubicin—muscle cancer	0.000703	0.00651	CcSEcCtD
Azelastine—Amenorrhoea—Doxorubicin—muscle cancer	0.000698	0.00646	CcSEcCtD
Azelastine—Viral infection—Doxorubicin—muscle cancer	0.000679	0.00628	CcSEcCtD
Azelastine—Thinking abnormal—Doxorubicin—muscle cancer	0.00067	0.0062	CcSEcCtD
Azelastine—Glossitis—Doxorubicin—muscle cancer	0.000666	0.00616	CcSEcCtD
Azelastine—Lacrimation increased—Doxorubicin—muscle cancer	0.000666	0.00616	CcSEcCtD
Azelastine—Herpes simplex—Doxorubicin—muscle cancer	0.000666	0.00616	CcSEcCtD
Azelastine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000663	0.00613	CcSEcCtD
Azelastine—Ulcer—Doxorubicin—muscle cancer	0.000649	0.006	CcSEcCtD
Azelastine—Malaise—Dactinomycin—muscle cancer	0.000644	0.00596	CcSEcCtD
Azelastine—Mouth ulceration—Methotrexate—muscle cancer	0.000641	0.00593	CcSEcCtD
Azelastine—Back pain—Vincristine—muscle cancer	0.000618	0.00571	CcSEcCtD
Azelastine—Myalgia—Dactinomycin—muscle cancer	0.000608	0.00563	CcSEcCtD
Azelastine—Dermatitis contact—Doxorubicin—muscle cancer	0.000606	0.00561	CcSEcCtD
Azelastine—Discomfort—Dactinomycin—muscle cancer	0.000601	0.00556	CcSEcCtD
Azelastine—Influenza like illness—Doxorubicin—muscle cancer	0.000596	0.00551	CcSEcCtD
Azelastine—Hypoaesthesia—Etoposide—muscle cancer	0.000591	0.00547	CcSEcCtD
Azelastine—Agitation—Vincristine—muscle cancer	0.000587	0.00543	CcSEcCtD
Azelastine—Infection—Dactinomycin—muscle cancer	0.000579	0.00536	CcSEcCtD
Azelastine—Vertigo—Vincristine—muscle cancer	0.000574	0.00531	CcSEcCtD
Azelastine—Eye disorder—Etoposide—muscle cancer	0.000555	0.00514	CcSEcCtD
Azelastine—Mouth ulceration—Doxorubicin—muscle cancer	0.000555	0.00513	CcSEcCtD
Azelastine—Flushing—Etoposide—muscle cancer	0.000551	0.0051	CcSEcCtD
Azelastine—Hypertension—Vincristine—muscle cancer	0.000551	0.0051	CcSEcCtD
Azelastine—Myalgia—Vincristine—muscle cancer	0.000544	0.00503	CcSEcCtD
Azelastine—Abnormal vision—Doxorubicin—muscle cancer	0.000535	0.00495	CcSEcCtD
Azelastine—Mental disability—Doxorubicin—muscle cancer	0.000533	0.00493	CcSEcCtD
Azelastine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000532	0.00492	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000531	0.00492	CcSEcCtD
Azelastine—Anaphylactic shock—Vincristine—muscle cancer	0.000521	0.00482	CcSEcCtD
Azelastine—Infection—Vincristine—muscle cancer	0.000518	0.00479	CcSEcCtD
Azelastine—Dysgeusia—Etoposide—muscle cancer	0.000507	0.00469	CcSEcCtD
Azelastine—Fatigue—Dactinomycin—muscle cancer	0.000503	0.00465	CcSEcCtD
Azelastine—Back pain—Etoposide—muscle cancer	0.0005	0.00463	CcSEcCtD
Azelastine—Pain—Dactinomycin—muscle cancer	0.000499	0.00461	CcSEcCtD
Azelastine—Eczema—Doxorubicin—muscle cancer	0.000496	0.00459	CcSEcCtD
Azelastine—Eye pain—Doxorubicin—muscle cancer	0.000493	0.00456	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—muscle cancer	0.000481	0.00445	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—muscle cancer	0.00048	0.00444	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000477	0.00441	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000475	0.00439	CcSEcCtD
Azelastine—Increased appetite—Doxorubicin—muscle cancer	0.000474	0.00439	CcSEcCtD
Azelastine—Paraesthesia—Vincristine—muscle cancer	0.000468	0.00433	CcSEcCtD
Azelastine—Malaise—Etoposide—muscle cancer	0.000466	0.00431	CcSEcCtD
Azelastine—Vertigo—Etoposide—muscle cancer	0.000465	0.0043	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—muscle cancer	0.000461	0.00427	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—muscle cancer	0.000461	0.00427	CcSEcCtD
Azelastine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00046	0.00426	CcSEcCtD
Azelastine—Cough—Etoposide—muscle cancer	0.000451	0.00418	CcSEcCtD
Azelastine—Fatigue—Vincristine—muscle cancer	0.000449	0.00416	CcSEcCtD
Azelastine—Hypertension—Etoposide—muscle cancer	0.000447	0.00413	CcSEcCtD
Azelastine—Pain—Vincristine—muscle cancer	0.000446	0.00412	CcSEcCtD
Azelastine—Constipation—Vincristine—muscle cancer	0.000446	0.00412	CcSEcCtD
Azelastine—Asthma—Methotrexate—muscle cancer	0.000445	0.00411	CcSEcCtD
Azelastine—Chest pain—Etoposide—muscle cancer	0.00044	0.00407	CcSEcCtD
Azelastine—Discomfort—Etoposide—muscle cancer	0.000435	0.00402	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—muscle cancer	0.00043	0.00398	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—muscle cancer	0.00043	0.00398	CcSEcCtD
Azelastine—Gastrointestinal pain—Vincristine—muscle cancer	0.000426	0.00394	CcSEcCtD
Azelastine—Confusional state—Etoposide—muscle cancer	0.000426	0.00394	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—muscle cancer	0.000422	0.0039	CcSEcCtD
Azelastine—Infection—Etoposide—muscle cancer	0.000419	0.00388	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—muscle cancer	0.000418	0.00387	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000413	0.00382	CcSEcCtD
Azelastine—Tachycardia—Etoposide—muscle cancer	0.000412	0.00381	CcSEcCtD
Azelastine—Body temperature increased—Vincristine—muscle cancer	0.000412	0.00381	CcSEcCtD
Azelastine—Abdominal pain—Vincristine—muscle cancer	0.000412	0.00381	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—muscle cancer	0.000399	0.00369	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000398	0.00368	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000393	0.00363	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—muscle cancer	0.000385	0.00356	CcSEcCtD
Azelastine—Asthma—Doxorubicin—muscle cancer	0.000385	0.00356	CcSEcCtD
Azelastine—Hypersensitivity—Vincristine—muscle cancer	0.000384	0.00355	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—muscle cancer	0.000379	0.00351	CcSEcCtD
Azelastine—Haematuria—Methotrexate—muscle cancer	0.000378	0.0035	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—muscle cancer	0.000376	0.00348	CcSEcCtD
Azelastine—Somnolence—Etoposide—muscle cancer	0.000375	0.00347	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—muscle cancer	0.000374	0.00346	CcSEcCtD
Azelastine—Asthenia—Vincristine—muscle cancer	0.000374	0.00346	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—muscle cancer	0.000371	0.00343	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—muscle cancer	0.00037	0.00343	CcSEcCtD
Azelastine—Rash—Dactinomycin—muscle cancer	0.000368	0.0034	CcSEcCtD
Azelastine—Fatigue—Etoposide—muscle cancer	0.000364	0.00337	CcSEcCtD
Azelastine—Constipation—Etoposide—muscle cancer	0.000361	0.00334	CcSEcCtD
Azelastine—Pain—Etoposide—muscle cancer	0.000361	0.00334	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000358	0.00331	CcSEcCtD
Azelastine—Diarrhoea—Vincristine—muscle cancer	0.000357	0.0033	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—muscle cancer	0.000356	0.00329	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—muscle cancer	0.000353	0.00327	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—muscle cancer	0.00035	0.00324	CcSEcCtD
Azelastine—Feeling abnormal—Etoposide—muscle cancer	0.000348	0.00322	CcSEcCtD
Azelastine—Nausea—Dactinomycin—muscle cancer	0.000346	0.0032	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—muscle cancer	0.000345	0.00319	CcSEcCtD
Azelastine—Dizziness—Vincristine—muscle cancer	0.000345	0.00319	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—muscle cancer	0.000343	0.00317	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—muscle cancer	0.000334	0.00309	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—muscle cancer	0.000334	0.00309	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—muscle cancer	0.000334	0.00309	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—muscle cancer	0.000333	0.00308	CcSEcCtD
Azelastine—Vomiting—Vincristine—muscle cancer	0.000331	0.00306	CcSEcCtD
Azelastine—Rash—Vincristine—muscle cancer	0.000329	0.00304	CcSEcCtD
Azelastine—Dermatitis—Vincristine—muscle cancer	0.000328	0.00304	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—muscle cancer	0.000327	0.00303	CcSEcCtD
Azelastine—Headache—Vincristine—muscle cancer	0.000326	0.00302	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—muscle cancer	0.000324	0.003	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—muscle cancer	0.000322	0.00298	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—muscle cancer	0.000311	0.00288	CcSEcCtD
Azelastine—Nausea—Vincristine—muscle cancer	0.00031	0.00286	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—muscle cancer	0.000309	0.00286	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000307	0.00284	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—muscle cancer	0.000306	0.00283	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—muscle cancer	0.000303	0.00281	CcSEcCtD
Azelastine—Asthenia—Etoposide—muscle cancer	0.000303	0.0028	CcSEcCtD
Azelastine—Back pain—Methotrexate—muscle cancer	0.0003	0.00277	CcSEcCtD
Azelastine—Pruritus—Etoposide—muscle cancer	0.000299	0.00276	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—muscle cancer	0.000297	0.00275	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—muscle cancer	0.000292	0.0027	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—muscle cancer	0.000289	0.00267	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—muscle cancer	0.000288	0.00266	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—muscle cancer	0.000287	0.00266	CcSEcCtD
Azelastine—Flushing—Doxorubicin—muscle cancer	0.000286	0.00265	CcSEcCtD
Azelastine—Malaise—Methotrexate—muscle cancer	0.000279	0.00258	CcSEcCtD
Azelastine—Dizziness—Etoposide—muscle cancer	0.000279	0.00258	CcSEcCtD
Azelastine—Vertigo—Methotrexate—muscle cancer	0.000278	0.00257	CcSEcCtD
Azelastine—Cough—Methotrexate—muscle cancer	0.00027	0.0025	CcSEcCtD
Azelastine—Vomiting—Etoposide—muscle cancer	0.000268	0.00248	CcSEcCtD
Azelastine—Rash—Etoposide—muscle cancer	0.000266	0.00246	CcSEcCtD
Azelastine—Dermatitis—Etoposide—muscle cancer	0.000266	0.00246	CcSEcCtD
Azelastine—Headache—Etoposide—muscle cancer	0.000264	0.00245	CcSEcCtD
Azelastine—Myalgia—Methotrexate—muscle cancer	0.000264	0.00244	CcSEcCtD
Azelastine—Chest pain—Methotrexate—muscle cancer	0.000264	0.00244	CcSEcCtD
Azelastine—Tension—Doxorubicin—muscle cancer	0.000263	0.00244	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—muscle cancer	0.000263	0.00243	CcSEcCtD
Azelastine—Discomfort—Methotrexate—muscle cancer	0.000261	0.00241	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—muscle cancer	0.000261	0.00241	CcSEcCtD
Azelastine—Back pain—Doxorubicin—muscle cancer	0.000259	0.0024	CcSEcCtD
Azelastine—Confusional state—Methotrexate—muscle cancer	0.000255	0.00236	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—muscle cancer	0.000253	0.00234	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—muscle cancer	0.000253	0.00234	CcSEcCtD
Azelastine—Infection—Methotrexate—muscle cancer	0.000251	0.00232	CcSEcCtD
Azelastine—Nausea—Etoposide—muscle cancer	0.000251	0.00232	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000249	0.0023	CcSEcCtD
Azelastine—Agitation—Doxorubicin—muscle cancer	0.000247	0.00228	CcSEcCtD
Azelastine—Malaise—Doxorubicin—muscle cancer	0.000242	0.00224	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—muscle cancer	0.000241	0.00223	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—muscle cancer	0.000237	0.00219	CcSEcCtD
Azelastine—Cough—Doxorubicin—muscle cancer	0.000234	0.00217	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—muscle cancer	0.000232	0.00214	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00023	0.00213	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—muscle cancer	0.000228	0.00211	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—muscle cancer	0.000228	0.00211	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—muscle cancer	0.000228	0.00211	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—muscle cancer	0.000227	0.0021	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—muscle cancer	0.000226	0.00209	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—muscle cancer	0.000225	0.00209	CcSEcCtD
Azelastine—Somnolence—Methotrexate—muscle cancer	0.000225	0.00208	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—muscle cancer	0.000223	0.00207	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—muscle cancer	0.000221	0.00204	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000219	0.00203	CcSEcCtD
Azelastine—Fatigue—Methotrexate—muscle cancer	0.000218	0.00202	CcSEcCtD
Azelastine—Infection—Doxorubicin—muscle cancer	0.000218	0.00201	CcSEcCtD
Azelastine—Pain—Methotrexate—muscle cancer	0.000216	0.002	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—muscle cancer	0.000214	0.00198	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—muscle cancer	0.000208	0.00193	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000207	0.00191	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—muscle cancer	0.0002	0.00185	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—muscle cancer	0.0002	0.00185	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000199	0.00185	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—muscle cancer	0.000197	0.00182	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—muscle cancer	0.000195	0.00181	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—muscle cancer	0.000195	0.0018	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—muscle cancer	0.000189	0.00175	CcSEcCtD
Azelastine—Pain—Doxorubicin—muscle cancer	0.000187	0.00173	CcSEcCtD
Azelastine—Constipation—Doxorubicin—muscle cancer	0.000187	0.00173	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—muscle cancer	0.000186	0.00172	CcSEcCtD
Azelastine—Asthenia—Methotrexate—muscle cancer	0.000181	0.00168	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—muscle cancer	0.00018	0.00167	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000179	0.00166	CcSEcCtD
Azelastine—Pruritus—Methotrexate—muscle cancer	0.000179	0.00165	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—muscle cancer	0.000173	0.0016	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—muscle cancer	0.000173	0.0016	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—muscle cancer	0.000173	0.0016	CcSEcCtD
Azelastine—Dizziness—Methotrexate—muscle cancer	0.000167	0.00155	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—muscle cancer	0.000161	0.00149	CcSEcCtD
Azelastine—Vomiting—Methotrexate—muscle cancer	0.000161	0.00149	CcSEcCtD
Azelastine—Rash—Methotrexate—muscle cancer	0.000159	0.00147	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—muscle cancer	0.000159	0.00147	CcSEcCtD
Azelastine—Headache—Methotrexate—muscle cancer	0.000158	0.00147	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—muscle cancer	0.000157	0.00145	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—muscle cancer	0.000155	0.00143	CcSEcCtD
Azelastine—Nausea—Methotrexate—muscle cancer	0.00015	0.00139	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—muscle cancer	0.00015	0.00139	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—muscle cancer	0.000145	0.00134	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—muscle cancer	0.000139	0.00129	CcSEcCtD
Azelastine—Rash—Doxorubicin—muscle cancer	0.000138	0.00128	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—muscle cancer	0.000138	0.00128	CcSEcCtD
Azelastine—Headache—Doxorubicin—muscle cancer	0.000137	0.00127	CcSEcCtD
Azelastine—Nausea—Doxorubicin—muscle cancer	0.00013	0.0012	CcSEcCtD
